HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Over The Counter 9 May 2023: Progressing The Global Self-Care Industry’s Sustainability Agenda With GSCF’s Padmaja Kamath

Executive Summary

In this episode, HBW Insight speaks to the Global Self-Care Federation’s director of regulatory and scientific affairs, Padmaja Kamath, about the organisation’s sustainability work. In 2019, GSCF published its Global Charter for Environmental Sustainability, which represented, Kamath notes, the global consumer healthcare industry’s “first commitment to drive sustainable self-care.” Kamath updates us on the progress of the charter, which calls on GSCF members to pledge to make progress on one or more of three key sustainability areas: plastics and packaging, pharmaceuticals in the environment and CO2 footprint. We dive a little deeper into some specific challenges within these areas, such as recyclable blister packs and supply chain emissions, with Kamath pointing also to an upcoming GSCF webinar on the latter.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts